The impact of present disease-modifying treatments (DMTs) in multiple sclerosis (MS) on nerve injury and reactive astrogliosis is still unclear. Therefore, we studied the effect of natalizumab treatment on the release of 2 brain-specific tissue damage markers into cerebrospinal fluid (CSF) in MS pat
β¦ LIBER β¦
Beyond axonal transection: Hippocampal damage in multiple sclerosis
β Scribed by Orhan Aktas; Hans-Peter Hartung
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 59 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Axonal damage in relapsing multiple scle
β
Martin Gunnarsson; Clas MalmestrΓΆm; Markus Axelsson; Peter SundstrΓΆm; Charlotte
π
Article
π
2010
π
John Wiley and Sons
π
English
β 185 KB
π 1 views
The path to damage in multiple sclerosis
β
Henry F. McFarland
π
Article
π
1999
π
John Wiley and Sons
π
English
β 89 KB
π 1 views
Axonal dysfunction in chronic multiple s
β
Stephen G. Waxman
π
Article
π
2008
π
John Wiley and Sons
π
English
β 94 KB
π 1 views
Quality of life in epilepsy, multiple sc
β
E. Ray Dorsey; Robert G. Holloway
π
Article
π
2007
π
John Wiley and Sons
π
English
β 79 KB
π 2 views
Axonal degeneration in multiple sclerosi
β
Peter K. Stys
π
Article
π
2004
π
John Wiley and Sons
π
English
β 162 KB
π 1 views
Neuronal damage in T1-hypointense multip
β
Marianne A. A. Van Walderveen; Frederik Barkhof; Petra J. W. Pouwels; Ronald A.
π
Article
π
1999
π
John Wiley and Sons
π
English
β 429 KB
π 1 views
Hypointense T1 lesions in multiple sclerosis patients correlate with axonal loss at autopsy and biopsy. We evaluated the chemical substrate of hypointense T1 lesions by using in vivo proton magnetic resonance spectroscopy, and analyzed the spectroscopic correlate of increased T1-relaxation time meas